Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 6 of 14, showing 5 Applications out of 67 total, starting on record 26, ending on 30

# Protocol No Study Title Investigator(s) & Site(s)

26.

ECCT/23/04/06   Moderna 1273
    A Phase 2/3, Randomized, Observer-Blind, Placebo‑Controlled Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA‑1273 SARS‑CoV‑2 Vaccine in Healthy Adolescents 12 to <18 Years of Age   
Principal Investigator(s)
1. Dr. Walter Otieno Otieno
Site(s) in Kenya
1. Kenya Medical Research Institute/USAMRU (Kisumu county)
2. Victoria Biomedical Research Institute (Kisumu county)
3. KEMRI/USAMRD (Kericho county)
4. KEMRI CMR-Kar Geno Research Centre (Kisumu county)
5. KEMRI CRDR - Clinical Research Nairobi (Siaya county)
6. KEMRI/ CDC (Kisumu county)
7. KEMRI (Kisumu county)
8. KEMRI Centre for Clinical Research Butere County Hospital (Kakamega county)
9. KAVI Institute of Clinical Reasearch, College of Health science (Nairobi City county)
 
View

27.

ECCT/23/03/03   Moderna 1273
    A Phase 2/3, Randomized, Observer-Blind, Placebo‑Controlled Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA‑1273 SARS‑CoV‑2 Vaccine in Healthy Adolescents 12 to <18 Years of Age   
Principal Investigator(s)
1. Prof. Walter Godfrey Jaoko Jaoko
Site(s) in Kenya
1. KAVI Institute of Clinical Reasearch, College of Health science (Nairobi City county)
2. Victoria Biomedical Research Institute (Kisumu county)
3. KEMRI/USAMRD (Kericho county)
4. Kenya Medical Research Institute/USAMRU (Kisumu county)
5. KEMRI CMR-Kar Geno Research Centre (Kisumu county)
6. KEMRI CRDR - Clinical Research Nairobi (Nairobi City county)
7. KEMRI/ CDC (Kisumu county)
8. KEMRI (Kisumu county)
9. KEMRI Centre for Clinical Research Butere County Hospital (Kakamega county)
 
View

28.

ECCT/22/10/04   IVI-AdCLD-CoV19-1
    A Phase IIb Multicenter, Observer-Blinded, Randomized, Placebo-Controlled Trial to Evaluate the Immunogenicity and Safety of the AdCLD-CoV19-1 in Healthy Adults aged 19 years old and above.   
Principal Investigator(s)
1. Fredrick Kipyego Sawe
Site(s) in Kenya
KEMRI WRP CRC KERICHO
 
View

29.

ECCT/21/07/01   RESOLVE
    A Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy of Voxelotor for the Treatment of Leg Ulcers in Patients with Sickle Cell DiseaseA Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy of Voxelotor for the Treatment of Leg Ulcers in Patients with Sickle Cell Disease   
Principal Investigator(s)
1. Bernhards Ragama Ogutu
2. Jessie Nyokabi Githanga
Site(s) in Kenya
1. Strathmore University Medical Center (Nairobi City county)
2. KEMRI Kondele children\'S Hospital (Kisumu county)
3. Gertrude\'s Children\'s Hospital (Nairobi City county)
 
View

30.

ECCT/21/10/02   RESOLVE
    A Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy of Voxelotor for the Treatment of Leg Ulcers in Patients with Sickle Cell Disease   
Principal Investigator(s)
1. Janet Oyieko
Site(s) in Kenya
1. KEMRI CCR- Butere County Hospital (Kisumu county)
2. Strathmore University (Nairobi City county)
3. KEMRI Kondele Children’s Hospital (Kisumu county)
4. KEMRI/CRDR Siaya Clinical Research Annex (Siaya county)
5. KEMRI CRDR Clinical Research Clinic Nairobi (Nairobi City county)
6. Gertrude’s Children’s Hospital (Nairobi City county)
 
View